Xoma Corp. Files SEC Form 4 Filing
Xoma Corp., a pharmaceutical preparations company based in California, has filed a SEC Form 4 filing with the U.S. Securities and Exchange Commission (SEC). The filing, which was posted on March 2, 2015, contains information on the company's ownership and transactions involving its equity securities.
The SEC Form 4 filing is a mandatory document that must be submitted by directors, officers, or owners of more than ten percent of a class of equity securities registered under Section 12 of the Securities Exchange Act of 1934. The filing provides information on the reporting person's relationship to the company and on purchases and sales of such equity securities.
The filing of SEC Form 4 by Xoma Corp. highlights the importance of disclosure in the financial markets. The SEC's requirement for publicly-traded companies to file such documents helps to maintain transparency and accountability in the industry.
Key Takeaways:
- Xoma Corp. is a pharmaceutical preparations company based in California, with its SEC file number being 0000791908-15-000029.
- The company filed a SEC Form 4 filing with the SEC on March 2, 2015, which contains information on the company's ownership and transactions.
- SEC Form 4 is a mandatory document that must be submitted by directors, officers, or owners of more than ten percent of a class of equity securities registered under Section 12 of the Securities Exchange Act of 1934.
- The filing provides information on the reporting person's relationship to the company and on purchases and sales of such equity securities.
Statistics:
- The SEC Form 4 filing was posted on March 2, 2015.
- The SIC code for Xoma Corp. is 2834, Pharmaceutical Preparations.
- The contact information for Xoma Corp. is 2910 SEVENTH ST, BERKELEY CA 94710, 5106441170.
- A total of one document was filed with the SEC Form 4 filing.
Sources:
- "SEC Filing" by Xoma Corp. (Form 4), filed on March 2, 2015, SEC file number 0000791908-15-000029.
- NewsRx, "Xoma Corp. SEC Filing" (March 2, 2015)